Page 50 - Relapse News Today : Breaking News, Live Updates & Top Stories | Vimarsana

We know that for this type of cancer, the prognosis is good, with more than 90% of patients be able to get rid of the disease. in these patients, we want to avoid as much as possible an over—treatment that can be considered in itself as a new disease, so that's why you want to identify the patients that are not likely to relapse. 0wkin aims to complement everyday clinical practice with its tool. it can already be used in european hospitals, and the company is working on an updated version for those in the uk. what does an oncologist, who's used to having difficult conversations with patients...

To get rid of the disease. in these patients, we want to avoid as much as possible an over—treatment that can be considered in itself as a new disease, so that's why you want to identify the patients that are not likely to relapse. 0wkin aims to complement everyday clinical practice with its tool. it can already be used in european hospitals, and the company is working on an updated version for those in the uk. what does an oncologist, who's used to having difficult conversations with patients, make of it, though? what we do now in terms of assessment of the risk is to have the standard info...

In these patients, we want to avoid as much as possible an over—treatment that can be considered in itself as a new disease. so that's why you want to identify the patients that are not likely to relapse. 0wkin aims to complement everyday clinical practice with its tool. it can already be used in european hospitals, and the company is working on an updated version for those in the uk. what does an oncologist, who's used to having difficult conversations with patients, make of it, though? what we do now in terms of assessment of the risk is to have the standard i information, the standard cli...

Returning within five years. we know that, for this type of cancer, the prognosis is good, with more than 90% of patients be able to... to get rid of the disease. in these patients, we want to avoid as much as possible an over—treatment that can be considered in itself as a new disease. so that's why you want to identify the patients that are not likely to relapse. owkin aims to complement everyday clinical practice with its tool. it can already be used in european hospitals, and the company is working on an updated version for those in the uk. what does an oncologist, who's used to having d...

This will provide some of the information needed to classify patients between having a high, intermediate or low risk of their disease returning within five years. we know that for this type of cancer, the prognosis is good, with more than 90% of patients being able to get rid of the disease. in these patients, we want to avoid as much as possible a heavy treatment that can be considered in itself as a new disease. so that's why you want to identify the patients that are not likely to relapse. owkin aims to complement everyday clinical practice with its tool. it can already be used in european...